AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Roche’s reported $750M PathAI deal shows pathology AI moving from venture story to strategic asset
Roche’s reported acquisition of PathAI for $750 million signals how pathology AI is becoming strategically valuable to major diagnostics and life sciences companies. The deal would mark another step in the consolidation of AI assets around incumbents with distribution, data, and clinical reach.
Labcorp and PathAI Push AI Digital Pathology Into Routine U.S. Diagnostics
Labcorp has expanded its partnership with PathAI to deploy the FDA-cleared AISight Dx platform across its U.S. anatomical pathology network and participating hospitals. The move is significant because it shifts AI pathology from pilot-stage promise toward scaled operational use in routine diagnostics, with implications for turnaround time, consistency, and downstream biomarker-driven care.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.